Clinical Trials Directory

Trials / Completed

CompletedNCT06111690

Blood Flow Restriction Training in Individuals Awaiting Total Knee Replacement

Feasibility of Prehabilitation Blood-flow Restriction Training in Individuals Awaiting Total Knee Replacement.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
The University of Texas Health Science Center at San Antonio · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The aim is to demonstrate that preoperative exercises (pre-habilitation) using blood-flow restriction training (BFRT) is safe, well tolerated, improves muscle function, decreases functional limitation, and increases physical activity in older adults awaiting total knee replacement (TKR).

Detailed description

Twenty individuals ≥60 years old awaiting TKR due to diagnosis of end-stage knee osteoarthritis who meet the inclusion/exclusion criteria will be invited to participate in a 6 weeks of low-intensity BFRT prehabilitation. We will assess muscle functional (i.e., cross-sectional area and intramuscular fatty content) using computerized tomography, quadriceps muscle strength using an isokinetic dynamometer, a battery of performance-based physical function, self-reported physical function and quality of life, and biomarkers of inflammation using blood serum. Feasibility assessment will be done by looking at safety (i.e., adverse events), compliance, and attrition rate.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood Flow Restriction Training (BFRT)Participants will be performing low-resistance exercise with (BFRT). Intervention will start at least seven days after initial evaluation, so it does not influence measures of real-time physical activity. We will use a log to register exercise completion and to record bilateral knee pain before, during and after each intervention session

Timeline

Start date
2022-09-23
Primary completion
2024-10-02
Completion
2024-12-02
First posted
2023-11-01
Last updated
2026-03-24
Results posted
2026-03-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06111690. Inclusion in this directory is not an endorsement.